QMC Development Capital Fund is divesting Corporación Dermoestética.
QMC announced its investment in the firm in 2006 and was the third shareholder with 5.12% until last March.
Since March, the fund, which is managed by N+1, sold almost half of its stake for more than €750,000 and will be listing the remaining 2.7%.
Among Dermoestética's major shareholders is the firm’s chairman José Maria Suescun, who holds 50.43%, and Banco de Valencia, with 8.67%.
Corporación Dermoestética operates around 50 clinics throughout Portugal and Spain. It offers cosmetic, plastic and reconstructive surgical procedures, as well as nutritional and cosmetic dentistry services. The firm also produces and markets cosmetic products.
Fund has raised €1bn of its €1.1bn target and plans to hold a final close in Q1 2020
GP will take a minority stake, with the Reisenthel family as majority shareholders
Horizon expects to merge the two IT services providers to create a business with 300 developers
EQT deploys capital from its EQT VIII fund, which hit its €10.75bn hard-cap in 2018